Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Veracyte reported $55.99M in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Agenus AGEN:US USD 190.9M 1.95M
Agilent A:US USD 1.67B 270M
Anika Therapeutics ANIK:US USD 28.69M 779K
Arrowhead Research ARWR:US USD 87.15M 34.86M
Bruker BRKR:US USD 1.05B 137.5M
Exact Sciences EXAS:US USD 367.35M 45.39M
Heron Therapeutics HRTX:US USD 77.9M 4.46M
Illumina ILMN:US USD 2.23B 543M
Immunogen IMGN:US USD 101.63M 20.23M
Intrexon XON:US USD 46.73M 31.91M
Karyopharm Therapeutics KPTI:US USD 61.56M 10.45M
Laboratory Of America LH:US USD 2.89B 192.9M
Ligand Pharmaceuticals LGND:US USD 98.93M 119K
Myriad Genetics MYGN:US USD 143.3M 6.1M
Rigel Pharmaceuticals RIGL:US USD 45.52M 19.69M
Roche Holding ROG:VX CHF 27.24B 170M
Sangamo BioSciences SGMO:US USD 57.84M 53.87M
Siemens SIE:GR EUR 43.03B 1.74B
Sonic Healthcare SHL:AU AUD 1.87B 217.77M
Thermo Fisher Scientific TMO:US USD 15.88B 1.23B
Veracyte VCYT:US USD 55.99M 6.62M
Waters WAT:US USD 801.95M 16.21M